Ceapro Inc., a biotechnology company, is engaged in the development and marketing of active ingredients in the United States, Germany, China, Canada and internationally. It operates in two segments, the active ingredient product technology industry and the cosmeceutical industry. The company is involved in the development and application of technology for the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to your extracts by supporting their use in cosmeceutical, nutraceutical and therapeutic products for humans and animals. The company’s products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupine peptides that are marketed for personal care, cosmetic, medical, and animal health industries through its direct sales and distribution partners; natural anti-aging skin care products; and veterinary therapeutics, such as oatmeal shampoos, ear cleaners, and skin conditioners/complexes. Its R&D or pre-commercial products and technologies comprise a platform that uses its beta glucan formulations to deliver compounds for treatments in the personal and health sectors; various novel enabling technologies, such as pressurized gas expanded drying technology; and technologies to improve the content of avenanthramides. The company has a collaboration with McMaster University to develop an inhalable therapeutic treatment for COVID-19; a research project with the University of Alberta to expand the use of PGX technology and generate targeted ingredients for applications in functional foods, dietary supplements, personal care and pharmaceuticals; a research collaboration with the Montreal Heart Institute for a clinical study evaluating avenantramide; and a research collaboration with the Angiogenesis Foundation. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada. and a research collaboration with the Angiogenesis Foundation. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada. and a research collaboration with the Angiogenesis Foundation. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.
How to buy Ceapro shares (czo.v) Tutorial guide
Are you interested in buying Ceapro (czo.v) shares on TSXV from Spain and through a regulated broker? Are you interested in the fact of making your monthly savings profitable and making profits in the stock market? Today I am going to show you how you can create an account at Degiro , a reliable German investment broker with low commissions, and how you can buy shares in Ceapro Inc. (CZO.V) (czo.v) quickly and easily.
The procedure is easy to follow :
- The first step is that we will register in Degiro, a broker platform where we can buy shares of the company Ceapro Inc. (CZO.V) with the ticker (czo.v).
- Next we will add funds to then execute the first investment in the stock market.
- Once we see the funds in our account, we will proceed to search for the Ceapro company using the TICKER, which is czo.v.
- To finish, we will only go on to adjust the number of shares to buy, the purchase price and the type of order.
Perhaps this tutorial has been a bit simple for you, so now you are going to see the entire purchase process with images:
Registration tutorial for DeGiro.
First of all, we will register an account in Degiro through the following link :
It will ask us for an email, a name and a password to enter, and then we must continue with the link that they have sent us by email.
Immediately Degiro will ask us for some data of interest with the interest of verifying our official identification . We will need to have at hand our passport, identity document or driver’s license, your mobile number and the number of the bank account that we will use to make our first deposit in IBAN format. If you do not know what this format is, you can review this simple tutorial article that we have prepared .
Once our account is credited we will be able to pay money from the Enter/Withdraw tab. We can make a bank transfer that will take between 1 to 2 days, or we can make the deposit instantly using Sofort, a 100% secure and very reliable payment gateway.
How to buy Ceapro (czo.v) shares through Degiro
As long as we have the capital we will be able to buy our first share. You can press the Place Order button that you will find in the right corner or use the Degiro search engine and type the ticker. In the next screenshot you will see that I have put the Amazon Ticker but you should enter (czo.v), the Ceapro ticker. As we are talking about an action, we will check that the related results are listed and there we will see to find Ceapro. The essential thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Ceapro Inc. (CZO.V) is listed on TSXV. This step is essential so do not make a mistake.
When making the order we have to pay special attention to what I am going to explain to you . We may place a limit or market order. Imagine that you want to buy a Ceapro share, but its price is currently higher. With a limit order we will adapt the value at which we plan to carry out the operation and until there are no shares selling at said value, the acquisition of the share will not be executed. With a market order, DeGiro will buy the number of shares we have proposed at the actual selling price, which is going to be very close to today’s trading price.
In all cases it is very convenient that you look at the type of position: fixed or of the day . To give an example, in Spain, the stock market is from morning until 1 in the afternoon, and in the USA it corresponds to the afternoon schedule in Spain. If an order is fixed, it will last until the point in which it manages to be executed, but if you select the “of the day” option, when the trading session ends, if it is not carried out, it will be deleted from your panel from Activity – Pending Orders.
I want this short article to have helped you to buy shares in Ceapro. Thank you.
|Name||Title||Salary||exercised||Year of birth|
|Mr. Gilles R. Gagnon MBA, M.Sc., MBA, ICD.D||Director, President and Director||480k||N/A||1954|
|Ms. Stacy Prefontaine CPA, CA||Financial Director and Sec. Corp.||195.25k||N/A||N/A|
|Dr. Bernhard Seifried||Senior Director of Research and Technology||N/A||N/A||N/A|
Recent events of :
We have no recent events for this company.